AstraZeneca's revenue ambitions hit by psoriasis drug setback – Telegraph.co.uk

Telegraph.co.ukAstraZeneca's revenue ambitions hit by psoriasis drug setbackTelegraph.co.ukThe two companies have been sharing development of as a treatment for psoriasis, psoriatic arthritis and axial spondyloarthritis. The drug already faces competition from Eli Lily and Novartis who are targeting launch imminently and have reported no …AstraZeneca under pressure as Amgen cuts collaboration on potential …Proactive Investors USA & CanadaAstraZeneca hit after psoriasis drug linked to suicide fearsReutersAmgen Ends Psoriasis-Drug Partnership With AstraZenecaWall Street JournalNasdaq -Yahoo Newsall 96 news articles »

[monetize id=”1″]
[monetize id=”2″]

Aloe Vera Psoriasis Treatment

LEO Pharma reports encouraging data from PSO-FAST clinical trial of Enstilar … – News-Medical.net

European Pharmaceutical ReviewLEO Pharma reports encouraging data from PSO-FAST clinical trial of Enstilar …News-Medical.net"These data are encouraging for the vast majority of psoriasis patients that are also suffering from itch related to their disease," said Dr. Craig Leonardi, a Clinical Professor of Dermatology at St. Louis University School of Medicine (United States …New data shows Enstilar provides rapid itch relief for psoriasis patientsEuropean Pharmaceutical ReviewInvestigational Aerosol Foam Brings Rapid Itch Relief for Patients with PlaqueMD Magazineall 10 news articles »

https://www.dpsw.org/psorasis